AAD 2026 spotlights this shift to evidence-led skincare, aligning derm insights with mass-market needs.

USA – Kenvue and Olay made waves at the American Academy of Dermatology (AAD) 2026 Annual Meeting in Denver, Colorado, from March 27–31, by unveiling cutting-edge derma-cosmetic innovations rooted in robust clinical research.
These advancements target ageing, hydration, UV defence, and acne care with science-backed solutions from Olay’s cell adhesion breakthroughs and Kenvue’s Neutrogena, Aveeno, and Rogaine portfolio.
Olay unveiled proprietary findings via transcriptomic and proteomic studies showing that ageing skin suffers major drops in cell adhesion, the connections that let skin cells link and signal, beyond mere collagen loss, which sparks wrinkles, sagging, roughness, and dullness, while clarifying why some skin ages more slowly.
These insights power Olay’s Triple Collagen Peptide tech in hits like Regenerist Micro-Sculpting Cream and Retinol24 Night Moisturizer, plus the fresh Regenerist Treatments lineup with Hexa-Repair Peptide Complex (Triple Collagen Peptide plus Argireline Peptide) for non-invasive boosts in firmness, texture, radiance, and volume—no lasers or needles needed.
Dr. Rolanda Wilkerson, Olay’s lead scientist, explained that this cell adhesion pivot crafts smarter anti-ageing that delivers real visible gains.
From Kenvue’s side, Neutrogena, Aveeno, and Rogaine debuted 20+ abstracts and onsite demos on UV tech advances, enduring moisture, barrier boosts, and acne fixes co-crafted with dermatologists and trichologists to rethink the beauty aisle for accessible, proven staples.
Dr. Michelle Bateson, Vice President and Head of North America Research and Development at Kenvue, stated, “We are contributing to an industry-wide reimagining of the beauty aisle by creating accessible, effective formulas that are backed by science and co-designed by dermatologists and trichologists.”
“Healthcare providers are the most trusted source for personal care advice, and our research demonstrates how blending clinical data with cultural relevance to address everyday skin health and beauty challenges is the key to forging trust and connection with healthcare providers and consumers.”
Neutrogena’s 15% vitamin C Collagen Bank Serum shines in fixing UV harm and fortifying barriers; Hyro Boost aids pre/post-procedure recovery by cutting redness and smoothing sensitive skin; Clear Pore Cleanser/Mask (3.5% benzoyl peroxide) fights blemishes sans barrier damage; and Helioplex 360 with BEMT filters blocks broad UV plus blue light.
Aveeno’s Skin Relief Healing Ointment beats petrolatum at locking in hydration, while Calm + Restore counters UV stress by hiking hyaluronic acid—spotlighting everyday wins where pros trust these over trends, though sun care lags consumer focus.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.